|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 15/14 | |
| C07H 5/10 | |||
| A61K 38/14 | |||
| G01N 33/53 | |||
| A61K 31/70 | |||
| C08B 1/00 |
| (11) | Number of the document | 2358731 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09833844.5 |
| Date of filing the European patent application | 2009-12-18 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/068790 |
| Date | 2009-12-18 |
| (87) | Number | WO 2010/071824 |
| Date | 2010-06-24 |
| (30) | Number | Date | Country code |
| 139224 P | 2008-12-19 | US |
| (72) |
BOSQUES, Carlos, J., US
MURPHY, Jennifer, Lynn, US
GUNAY, Nur, Sibel, US
SHRIVER, Zachary, US
LIU, Cuihua, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
675 West Kendall Street, Cambridge, MA 02142,
US
|
| (54) | METHODS RELATED TO MODIFIED GLYCANS |
| METHODS RELATED TO MODIFIED GLYCANS |